Pradžia › Židininis segmentinis glomerulosklerozė › Ohio
Židininis segmentinis glomerulosklerozė klinikiniai tyrimai Ohio
8 tyrimai dėl Židininis segmentinis glomerulosklerozė ieško dalyvių vietose Ohio.
Miestai Ohio
Oficialus tyrimo tekstas (anglų kalba)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #20, Cleveland
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Americare Kidney Institute - Brunswick, Brunswick
- The Kidney and Hypertension Center, Cincinnati
- Cincinnati Children's Hospital Medical Center, Cincinnati
- ir dar 2
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- Cleveland Clinic - Cleveland- Site Number : 8400029, Cleveland
Renkami dalyviai2 fazė
Amžius nuo 16 iki 75 · Visoms lytims · Atnaujinta 2026-09-23 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- Akron Children's Hospital, Akron
Renkami dalyviai
Iki 75 metų · Visoms lytims · Atnaujinta 2026-08-28 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- Akron Children's Hospital, Akron
Renkami dalyviai
Iki 21 metų · Visoms lytims · Atnaujinta 2026-08-28 · NCT02235857Nephrotic Syndrome Study Network
- Cleveland Clinic, Cleveland
- The Ohio State University Wexner Medical Center, Columbus
Renkami dalyviaiStebimasis tyrimas
Iki 80 metų · Visoms lytims · Atnaujinta 2026-06-10 · NCT01209000NEPTUNE Match Study
- Cleveland Clinic Foundation, Cleveland
Renkami dalyviai
Amžius nuo 1 iki 80 · Visoms lytims · Atnaujinta 2026-06-10 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- Nationwide Children's Hospital, Columbus
Renkami dalyviai2 fazė
Amžius nuo 1 iki 17 · Visoms lytims · Atnaujinta 2026-05-12 · NCT05003986Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.